Bion Pharma, the New Jersey startup freshly launched by a cadre of former execs from Indian generic drugmaker Ranbaxy, has raised $21 million from two investors, according to a regulatory filing. The company’s aiming to raise $30 million. Five execs at the U.S. branch of Ranbaxy quit last month, and aim through this Princeton-based startup to […]
A cadre of former execs at Indian generic drugmaker Ranbaxy’s US branch quit last month and have launched a startup in New Jersey. Called Bion Pharma, it will help Indian and European drugmakers expand receive regulatory clearance and distribution rights in the world’s largest drug market – the USA. Economic Times reports: The top team of Bion […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.